The Year in Lipid Disorders Volume 1

Clinical Publishing, June 2007, Pages: 402

Lipid disorders are among the primary risk factors in developing atherosclerosis and heart disease. Cardiovascular diseases are the leading cause of death world-wide in both genders. This book provides the inquiring physician with an up-to-date insight into the latest research into lipid disorders, and the implications of this research for daily clinical practice. The book provides an overview of the latest developments in this complex field by reviewing the most significant papers published in the medical journals on lipid disorders over the eighteen months to December 2006. The Year in Lipid Disorders will be an essential element of the reference library for all cardiovascular physicians.

Benefits:

- Literature update on a key risk factor in cardiovascular disease
- Enables the doctor to survey the latest literature with the assistance of expert reviewers

Readership:

- General physicians
- Cardiologists
- Diabetologists
- Nephrologists
- Doctors in training

Editors and contributors

Part I: Clinical aspects in coronary artery disease

1. Metabolic syndrome, diabetes and cardiovascular risk
Mohamed Ahmed, Christopher Byrne

2. Use of novel risk factors in prevention and therapeutic strategies
Naveed Sattar

3. Diet and exercise in the prevention and treatment of diabetes and coronary heart disease
Gang Hu, Jaakko Tuomilehto

4. Technologies for assessment of atherosclerotic burden in man
Colin Berry, Jean-Claude Tardif

Part II: Lipids, lipoproteins and atherosclerosis

5. High-density lipoprotein structure and metabolism: regulation by cell membrane receptors
Kerry-Anne Rye, Philip Barter

6. Oxidative stress, lipoprotein oxidation and atherosclerosis
Richard James

7. Metabolism of apolipoprotein B-100-containing lipoproteins in dyslipidaemias
Gerald Watts, Dick Chan, Hugh Barrett

8. Sex-specific aspects of dyslipidaemia and atherosclerosis
Ian Godsland

Part III: Prevention and treatment strategies

9. New clinical trials of lipid-regulating agents
Anders Olsson

10. Genetics of dyslipidaemia and coronary risk (personalized lipid-lowering treatment)
Philippa Talmud

11. Application of proteomic, metabolomic and lipidomic approaches to coronary heart disease risk prediction
Fergus McTaggart

12. Nuclear receptors (PPARs, LXRs) and their role in regulating lipid metabolism
John Millar

Part IV: Infection, inflammation and secondary causes of atherosclerosis

13. Inflammation, inflammatory disease, and coronary atherosclerosis
Robert Rosensen, Alisa Koch

14. Kidney disease, end-stage renal failure and accelerated coronary heart disease
Sabin Shurraw, Marcello Tonelli

15. Lipids and infection
Margaret Bassendine

16. Haemostasis–dyslipidaemia interactions in coronary heart disease
Vellore Karthikeyan, Gregory Lip

Acronyms/abbreviations
Index of papers reviewed
General index

Edited by:

C Packard, R&D Director, North Glasgow Division, Greater Glasgow Health Board, Glasgow Royal Infirmary, Glasgow, UK.

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Also available

• The Year in Lipid Disorders Volume 2

Customers who bought this item also bought

• UK Electronic Cigarettes Market 2011-2015
• Cholesterol & Other Cardiovascular Testing - Global Strategic Business Report
• Nitric Oxide - Therapeutics, Markets and Companies
• Biomarkers - Technologies, Markets and Companies
• UK/Ireland Biotechnology Sector: Clinical Phase Drug Development Pipeline
• Cord Blood Banking - United Kingdom Add-On Module
• Gene Therapy - Technologies, Markets and Companies
• RNAi - Technologies, Markets and Companies
• Future Horizons in the UK Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment
• Coronary Atherosclerosis. Current Management and Treatment